Latest Regulatory Risk News

Contact Energy has announced a $525 million equity raise to accelerate its renewable energy projects, following a strong first half of FY26 with significant profit growth and strategic acquisitions.

St George Mining has won preferential tax treatment from the Minas Gerais government, cutting development costs for its flagship Araxá Project in Brazil. This support bolsters the company’s ambitions to establish a world-class niobium and rare earths operation.

Tamboran Resources Corporation reported a 26% reduction in half-year losses as it progresses key natural gas projects in Australia’s Beetaloo Basin and prepares for a major acquisition of Falcon Oil & Gas Ltd.

Origin Energy reports a 45% drop in half-year profit amid lower gas earnings and ongoing investments, while extending Eraring Power Station operations to 2029 to support NSW energy security.

Meteoric Resources has successfully commissioned its Mixed Rare Earth Carbonate pilot plant in Brazil, achieving strong recovery rates and production outputs that validate its processing approach and de-risk the Caldeira project.

DPM Metals Inc. delivered record revenues and earnings in 2025, driven by higher metal prices and stable production, while completing the strategic acquisition of Adriatic Metals plc, adding the Vareš polymetallic mine to its portfolio. The company outlines a robust three-year growth plan focused on expanding production and exploration.

Arena REIT reported a remarkable 202% jump in net profit for the half-year ending December 2025, driven by significant property revaluation gains and steady rental income growth. Distributions rose 5%, supported by an expanded and fully leased portfolio of early learning and healthcare properties.

Evolution Energy Minerals Limited has announced a renounceable pro-rata entitlement offer to raise up to $4.03 million, aiming to fund exploration and development of its Tanzanian copper and graphite assets. The offer includes free attaching options and is partially underwritten, reflecting both opportunity and risk amid regulatory challenges.

Commonwealth Bank of Australia reported a 5% increase in statutory net profit after tax to $5.367 billion for the half year ended December 2025, supported by lending growth and improved credit quality despite margin pressures and higher expenses. The bank declared a fully franked interim dividend of $2.35 per share.

Beach Energy reported a resilient first half of FY26, overcoming Cooper Basin floods to deliver solid earnings boosted by LNG cargoes and higher gas prices. The company’s operational safety and environmental efforts underpin a confident outlook as key projects ramp up.

Island Pharmaceuticals has raised $9 million to advance its antiviral drug Galidesivir through the FDA’s Animal Rule pathway, targeting inclusion in the US Strategic National Stockpile for biodefense viruses.

Island Pharmaceuticals secures FDA confirmation on Galidesivir’s development under the Animal Rule, unlocking a streamlined two-stage approval process and significant commercial incentives.